The Integra-D trial shows the device, which provides cardiac contractility modulation and defibrillation, also eases symptoms ...

Vocal monitoring has the potential to identify HF patients with worsening congestion early and prevent acute decompensation.

It’s meant to support the valve guidelines and aid in disentangling the complexities of the tricuspid field, one of the ...

The new SCAI initiative brings optimism for a population that has seen little innovation or changes to treatment paradigms in ...

In 2023, there were 437 million disability-adjusted life-years lost from cardiovascular disease, up from 320 million in 1990.

Implanting pacemakers in those who meet criteria for prophylactic use appears to be overtreating some patients.

The drug met primary safety and efficacy outcomes, with full results to be presented at the AHA Scientific Sessions.

TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of ...

The trial’s findings will dampen enthusiasm for the drug in stroke recovery, though research questions remain, one expert ...

The paper aims to increase awareness of cardiac long COVID and make management quicker, more accurate, and safer.

TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of ...

The two observational studies have limitations, including use of older GLP-1s, but still point to the strengths of bariatric ...